You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries
|
|---|---|
| Published in |
Globalization and Health, October 2011
|
| DOI | 10.1186/1744-8603-7-39 |
| Pubmed ID | |
| Authors |
Suerie Moon, Elodie Jambert, Michelle Childs, Tido von Schoen-Angerer |
| Abstract |
Tiered pricing - the concept of selling drugs and vaccines in developing countries at prices systematically lower than in industrialized countries - has received widespread support from industry, policymakers, civil society, and academics as a way to improve access to medicines for the poor. We carried out case studies based on a review of international drug price developments for antiretrovirals, artemisinin combination therapies, drug-resistant tuberculosis medicines, liposomal amphotericin B (for visceral leishmaniasis), and pneumococcal vaccines. |
X Demographics
The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 6 | 19% |
| Canada | 2 | 6% |
| Brazil | 1 | 3% |
| United States | 1 | 3% |
| France | 1 | 3% |
| Unknown | 21 | 66% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 24 | 75% |
| Practitioners (doctors, other healthcare professionals) | 4 | 13% |
| Scientists | 4 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 249 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 2% |
| Brazil | 4 | 2% |
| Germany | 2 | <1% |
| Kenya | 2 | <1% |
| Mexico | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 235 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 50 | 20% |
| Student > Master | 48 | 19% |
| Student > Ph. D. Student | 29 | 12% |
| Student > Bachelor | 28 | 11% |
| Student > Doctoral Student | 15 | 6% |
| Other | 39 | 16% |
| Unknown | 40 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 54 | 22% |
| Social Sciences | 32 | 13% |
| Agricultural and Biological Sciences | 25 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 17 | 7% |
| Economics, Econometrics and Finance | 16 | 6% |
| Other | 61 | 24% |
| Unknown | 44 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 89. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2022.
All research outputs
#475,521
of 25,374,917 outputs
Outputs from Globalization and Health
#50
of 1,226 outputs
Outputs of similar age
#1,772
of 148,287 outputs
Outputs of similar age from Globalization and Health
#2
of 13 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,226 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 148,287 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.